Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Shattuck Labs	Indivior	Antibe Therapeutics	Antibe Therapeutics	Repare Therapeutics
Symbol	NASDAQ:STTK	OTCMKTS:INVVY	NASDAQ:ATBPD	OTCMKTS:ATBPD	NASDAQ:RPTX
Price Information
Current Price	$26.79	$10.31	$3.28	$3.38	$32.38
52 Week Range	Buy	Buy	N/A	N/A	Buy
MarketRank™
Overall Score	1.5	0.8	0.1	0.1	1.6
Analysis Score	3.5	0.0	0.0	0.0	2.5
Community Score	3.5	1.9	0.0	0.0	3.9
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	0.8
Earnings & Valuation Score	0.6	1.9	0.6	0.6	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	N/A	N/A	Buy
Consensus Price Target	$45.60	N/A	N/A	N/A	$40.20
% Upside from Price Target	70.21% upside	N/A	N/A	N/A	24.15% upside
Trade Information
Market Cap	$1.12 billion	$1.51 billion	$1.27 billion	$1.31 billion	$1.20 billion
Beta	N/A	0.3	0.57	0.57	N/A
Average Volume	145,557	8,310	29,710	29,710	140,263
Sales & Book Value
Annual Revenue	N/A	$785 million	$7.51 million	$7.51 million	N/A
Price / Sales	N/A	1.93	169.02	174.18	N/A
Cashflow	N/A	$2.06 per share	N/A	N/A	N/A
Price / Cash	N/A	5.01	N/A	N/A	N/A
Book Value	N/A	$1.43 per share	$0.10 per share	$0.10 per share	N/A
Price / Book	N/A	7.21	32.80	33.80	N/A
Profitability
Net Income	N/A	$134 million	$-14,540,000.00	$-14,540,000.00	N/A
EPS	N/A	$1.15	($0.50)	($0.50)	N/A
Trailing P/E Ratio	0.00	N/A	N/A	N/A	0.00
Forward P/E Ratio	N/A	17.47	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-31.93%	-273.96%	-273.96%	N/A
Return on Equity (ROE)	N/A	-4.15%	-176.23%	-150.49%	N/A
Return on Assets (ROA)	N/A	-0.26%	-106.91%	-98.51%	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	2.89%	N/A	N/A	N/A
Current Ratio	8.63%	1.82%	6.55%	5.97%	35.44%
Quick Ratio	8.63%	1.69%	5.95%	5.42%	35.44%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	64.81%
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	59	788	47	47	102
Shares Outstanding	41.91 million	146.92 million	387.00 million	387.00 million	36.98 million
Next Earnings Date	8/9/2021 (Estimated)	N/A	N/A	N/A	8/12/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Repare Therapeutics (NASDAQ:RPTX) Releases Earnings Results, Misses Estimates By $0.07 EPS americanbankingnews.com - May 14 at 11:50 AM
	Repare Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results wallstreet-online.de - May 14 at 1:54 AM
	Repare Therapeutics (NASDAQ:RPTX) Sees Large Volume Increase americanbankingnews.com - May 12 at 11:50 AM
	Here's Why We're Not At All Concerned With Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation finance.yahoo.com - May 11 at 1:28 PM
	Repare Therapeutics (NASDAQ:RPTX) Shares Gap Down to $33.04 americanbankingnews.com - May 7 at 11:52 AM
	Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-6306, a First-in-Class, Selective, Oral Inhibitor of PKMYT1 finance.yahoo.com - May 3 at 7:44 AM
	Zacks: Brokerages Anticipate Repare Therapeutics Inc. (NASDAQ:RPTX) Will Announce Earnings of -$0.49 Per Share americanbankingnews.com - May 2 at 6:16 PM
	Repare Therapeutics (NASDAQ:RPTX) Shares Gap Down to $33.10 americanbankingnews.com - April 29 at 3:36 PM
	Morgan Stanley Raises Repare Therapeutics (NASDAQ:RPTX) Price Target to $45.00 americanbankingnews.com - April 26 at 10:58 AM
	Morgan Stanley Increases Repare Therapeutics (NASDAQ:RPTX) Price Target to $45.00 marketbeat.com - April 26 at 9:21 AM
	Repare Therapeutics (NASDAQ:RPTX) Stock Price Down 2.5% americanbankingnews.com - April 21 at 2:02 PM
	Repare Therapeutics to Present at the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference finance.yahoo.com - April 13 at 9:07 AM
	Repare Therapeutics to Highlight Program Progress for RP-6306 at Today’s Virtual Investor Day Event finance.yahoo.com - April 8 at 1:08 PM
	Valence Discovery to Support Repare Therapeutics on AI-Enabled Drug Discovery in Precision Oncology finance.yahoo.com - March 18 at 12:36 PM
	Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results finance.yahoo.com - March 4 at 8:18 PM
	Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation finance.yahoo.com - February 23 at 12:00 PM
	Could The Repare Therapeutics Inc. (NASDAQ:RPTX) Ownership Structure Tell Us Something Useful? finance.yahoo.com - February 9 at 5:07 PM
	Repare Therapeutics to Present at Virtual Investor Conferences in January finance.yahoo.com - January 4 at 9:38 AM
	Hedge Fund and Insider Trading News: Paul Marshall, Larry Robbins, Alden Global Capital, Square Inc (SQ), Repare Therapeutics Inc (RPTX), and More insidermonkey.com - December 31 at 7:32 PM
	Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans finance.yahoo.com - December 31 at 7:32 PM
	Repare Therapeutics Inc. (RPTX) realmoney.thestreet.com - December 30 at 11:30 PM
	Repare Therapeutics: CRISPR-Enabled Technology Might Unlock New Therapies seekingalpha.com - December 30 at 6:30 PM
	What Canada needs to do to build a world-class biotech sector theglobeandmail.com - December 23 at 10:57 PM
	Repare Therapeutics Inc Registered Shs Overweight markets.businessinsider.com - December 17 at 11:09 PM
	Repare Therapeutics Added to the NASDAQ Biotechnology Index finance.yahoo.com - December 17 at 6:08 PM
	Is RPTX A Good Stock To Buy Now? finance.yahoo.com - December 15 at 11:57 PM

Date	Company	Brokerage	Action
4/20/2021	Shattuck Labs	Berenberg Bank	Initiated Coverage
1/20/2021	Shattuck Labs	Citigroup	Boost Price Target
1/11/2021	Shattuck Labs	Evercore ISI	Initiated Coverage
11/3/2020	Shattuck Labs	Smith Barney Citigroup	Initiated Coverage
11/3/2020	Shattuck Labs	Cowen	Initiated Coverage
11/3/2020	Shattuck Labs	Needham & Company LLC	Initiated Coverage
11/3/2020	Shattuck Labs	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Initiated Coverage
7/27/2020	Indivior	Jefferies Financial Group	Upgrade
7/27/2020	Indivior	Stifel Nicolaus	Upgrade
4/26/2021	Repare Therapeutics	Morgan Stanley	Boost Price Target
12/29/2020	Repare Therapeutics	Northland Securities	Reiterated Rating
9/17/2020	Repare Therapeutics	Bloom Burton	Reiterated Rating
7/14/2020	Repare Therapeutics	The Goldman Sachs Group	Initiated Coverage
7/14/2020	Repare Therapeutics	Piper Sandler	Initiated Coverage

(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources